Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study

Por Yao, James C., Phan, Alexandria T., Chang, David Z., Wolff, Robert A., Hess, Kenneth, Gupta, Sanjay, Jacobs, Carmen, Mares, Jeannette E., Landgraf, Andrea N., Rashid, Asif, Meric-Bernstam, Funda
Publicado em 2008